浙江健新原力制药有限公司

Innoforce’s
Business

Innoforce is a premier CDMO focusing on Advanced Therapy Medicinal Products (“ATMP”). We have developed comprehensive technology platforms to enable end-to-end manufacture of high-quality plasmid DNA, RNA, LNP, exosomes, viral vectors, and cell therapeutics. Our state-of-the-art facility is designed to meet the cGMP standards of the FDA, EMA, and NMPA. We have also implemented rigorous policies and procedures to safeguard our clients’ IP. Innoforce is led by an industry-seasoned management team with extensive experience leading multiple innovative products from development to commercialization in the US, EU, and China. Our goal is to accelerate the development and commercialization of innovative products globally.

With our expertise in process development and manufacturing, Innoforce can be a trusted partner from R&D through commercialization.

Leadership Team

Innoforce is led by an industry-seasoned management team who were successful in leading multiple innovative products from development to commercialization. We want to help your projects achieve the same success with our expertise.

IP Protection

Protecting our client's intellectual property (IP) is Innoforce's top priority. As a professional global CDMO, we have implemented rigorous policies and procedures to ensure the strictest file management and access control to safeguard your IP. We assign separate teams and rooms for each of our clients, eliminating any opportunity to allow information sharing between projects. Additionally, Innoforce does not have a product pipeline; therefore, that we are fully committed to your success without any conflict of interest.